Catalyst Wire Dossier Catalyst Wire Dossier

Feraccru

ferric maltol · Shield Therapeutics
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Feraccru, covering 2020-09-25 to 2026-06-25. Get the full timeline:

Most recent: EMA Authorised: Feraccru (ferric maltol) — Norgine B.V.

See pricing